CMS finalized a 2.3% payment update for Medicare ambulatory surgery centers in calendar year 2027, 0.1 percentage point below the 2.4% it proposed in July. The final rule, CMS-1850-F, came out on November 4, 2026 and sets rates for about 6,400 ASCs and about 3,500 hospitals, according to CMS.

How CMS built the 2.3% figure

CMS starts with a projected hospital market basket increase of 3.2%, the same figure it used in the proposed rule. It then subtracts a productivity adjustment of 0.9 percentage points. The proposal subtracted 0.8 points, which is why the final update fell from 2.4% to 2.3%.

The ASC update factor uses the same method. CMS bases it on the inpatient market basket of 3.2%, reduced by the same 0.9 points. The hospital outpatient update is also 2.3%, so ASC and hospital outpatient rates move by the same percentage.

Both updates apply only to facilities that meet quality reporting requirements. For an ASC that does not, CMS cuts 2 percentage points, according to its fact sheet on the final rule. The update then drops from 2.3% to 0.3%.

Proposed rule and final rule side by side

Most figures moved by a small amount between July 2 and November 4. The largest changes came in the 340B drug payment policy, which affects hospital outpatient departments rather than ASCs.

ItemProposed rule (July 2, 2026)Final rule (November 4, 2026)
ASC payment update2.4%2.3%
Hospital outpatient update2.4%2.3%
Market basket3.2%3.2%
Productivity adjustment0.8 point0.9 point
Inpatient Only list removals638 services637 services
Alaska and Hawaii cost adjustment$55 million$66 million
340B drug payment rateASP minus 33.4%ASP minus 28%
340B prospective offset3%2%

Source: CMS fact sheets on the CY2027 OPPS and ASC proposed rule (July 2, 2026) and final rule (November 4, 2026). ASP is average sales price.

What the 2.3% means in dollars

The percentage applies to Medicare ASC payments only. Take an ASC that bills $1,000,000 a year to Medicare on a fixed case mix. A 2.3% update adds $23,000. The same ASC after the 2-point penalty gets 0.3%, or $3,000. The penalty removes $20,000, which is 87.0% of the raise.

Case mix changes the result, because CMS sets each procedure's rate from its own relative weight. The final rule does not give a single conversion factor in the fact sheet or press release, so a practice needs the rule's payment addenda to price its own top procedures.

The final rule also keeps expanding the ASC covered procedures list. CMS says it adds several hundred surgical procedures but does not give an exact count in its press release.

Other changes that touch outpatient billing

CMS estimates that its payment change for imaging at off-campus hospital outpatient departments will cut Medicare Part B spending by about $260 million in the first year. About $190 million of that is Part B savings and about $70 million is lower beneficiary premiums. CMS projects more than $9 billion in savings from 2027 to 2036. Beneficiary cost-sharing falls by about $70 million in the first year.

Prior authorization now covers eight more botulinum toxin injection codes. CMS reports that claims for those codes rose 42.8% from 2017 to 2024, an average of 4.6% a year. Over the same period, total hospital outpatient service volume fell 8.3%.

The rule removes 637 services from the Medicare Inpatient Only list in the second year of a three-year phase-out. Procedures that leave the list can be paid in an outpatient setting, which matters to any practice that performs surgery in an ASC or an outpatient department.

Behavioral health programs get minimum hours. An intensive outpatient program must provide at least 9 hours of services a week. A partial hospitalization program must provide at least 20 hours. CMS also sets community mental health center costs at 40% of the hospital-based costs for those programs.

The 340B drug payment change

CMS will pay for drugs acquired through the 340B program at average sales price minus 28%. The proposal was minus 33.4%. CMS estimates the change lowers Original Medicare drug payment by $4.35 billion in the first year and beneficiary drug payments by $1.1 billion. The press release puts the combined figure at about $5.45 billion for 2027. Average beneficiary savings are $900 in 2027.

The payment change is budget neutral, so non-drug outpatient payments rise by an equivalent amount. The separate offset for the 340B remedy rises from 0.5% to 2% in 2027. It stays in place until the cumulative reduction reaches $7.8 billion, which CMS estimates will happen in 2031. The proposal had estimated 2029.

For a practice that does not run a 340B program, the effect shows up only in outpatient department rates. A practice that shares an outpatient contract with a hospital system can check whether the contract references the Medicare hospital outpatient rates.

What to check before January 1

The final rule covers about 3,500 hospitals and about 6,400 ASCs, and it sets the update at 2.3%, 0.1 point under the proposal.

Sources

Talk to us

Fifteen minutes about your practice and the systems you run.

Book a demo